These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
548 related articles for article (PubMed ID: 36158256)
21. LRP16 prevents hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling. Shao L; Jing W; Wang L; Pan F; Wu L; Zhang L; Yang P; Hu M; Fan K J Mol Med (Berl); 2018 Jun; 96(6):547-558. PubMed ID: 29748698 [TBL] [Abstract][Full Text] [Related]
22. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway. Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway. Tang H; Zhao H; Yu ZY; Feng X; Fu BS; Qiu CH; Zhang JW Dig Liver Dis; 2019 Sep; 51(9):1314-1322. PubMed ID: 30948333 [TBL] [Abstract][Full Text] [Related]
24. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway. Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444 [TBL] [Abstract][Full Text] [Related]
25. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway. Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635 [TBL] [Abstract][Full Text] [Related]
26. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
27. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway. Zhang T; Ma Z; Liu L; Sun J; Tang H; Zhang B; Zou Y; Li H Cell Death Dis; 2018 Jun; 9(6):675. PubMed ID: 29867138 [TBL] [Abstract][Full Text] [Related]
28. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p. Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012 [TBL] [Abstract][Full Text] [Related]
29. β-Sitosterol suppresses hepatocellular carcinoma growth and metastasis via FOXM1-regulated Wnt/β-catenin pathway. Chen Y; Yang Y; Wang N; Liu R; Wu Q; Pei H; Li W J Cell Mol Med; 2024 Feb; 28(3):e18072. PubMed ID: 38063438 [TBL] [Abstract][Full Text] [Related]
30. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling. Qiao W; Wang H; Zhang X; Luo K Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway. Xiong L; Tang Y; Tang J; Liu Z; Wang X Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357 [No Abstract] [Full Text] [Related]
32. miR-186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1-mediated Wnt/β-catenin signaling. Wang H; Ou J; Jian Z; Ou Y J Cell Physiol; 2019 Dec; 234(12):23135-23145. PubMed ID: 31140612 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway. Li GH; Ma ZH; Wang X Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Bai Z; Xia X; Lu J Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177 [TBL] [Abstract][Full Text] [Related]
35. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia. Guo BJ; Ruan Y; Wang YJ; Xiao CL; Zhong ZP; Cheng BB; Du J; Li B; Gu W; Yin ZF J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868 [TBL] [Abstract][Full Text] [Related]
36. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627 [No Abstract] [Full Text] [Related]
37. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395 [TBL] [Abstract][Full Text] [Related]
38. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway. Liu FH; Cui YP; He YK; Shu RH Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557 [TBL] [Abstract][Full Text] [Related]
39. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Lei T; Zhu X; Zhu K; Jia F; Li S Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558 [TBL] [Abstract][Full Text] [Related]
40. Sex Comb on Midleg Like-2 Accelerates Hepatocellular Carcinoma Cell Proliferation and Metastasis by Activating Wnt/β-Catenin/EMT Signaling. Du L; Wang L; Yang H; Duan J; Lai J; Wu W; Fan S; Zhi X Yonsei Med J; 2021 Dec; 62(12):1073-1082. PubMed ID: 34816637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]